Review: mitochondrial dysfunction as a proposed mediator of endplate chondrocyte senescence
This abstract describes a review proposing that mitochondrial homeostatic imbalance is a central mediator of endplate chondrocyte senescence in intervertebral disc degeneration, and it evaluates interventions targeting mitochondrial homeostasis. [1]
Automatic summary · not editorially reviewed
The key findings
The abstract proposes mitochondrial homeostatic imbalance as the central pathological key mediator of endplate chondrocyte senescence in intervertebral disc degeneration. [1]
The review examines how mitochondrial reactive oxygen species activate the NLRP3 inflammasome and NF-κB pathways to drive the senescence-associated secretory phenotype. [1]
The review evaluates targeted antioxidants, NAD+ precursors and mitochondrial transplantation, and discusses cartilage-penetrating nanocarriers and gene-editing technologies for delivery. [1]
The source at a glance
- Study type / format
- Review (abstract only)
- Population / context
- Endplate chondrocytes in intervertebral disc degeneration, as described in a review
- Summary based on
- Study abstract
- Original publication
- August 13, 2026
Proposed mitochondrial role in endplate chondrocyte senescence
The abstract frames intervertebral disc degeneration as a leading global cause of chronic pain and functional impairment. It states that senescence of endplate chondrocytes is associated with the degeneration cascade, with mitochondrial homeostatic imbalance proposed as the central pathological key mediator. Endplate chondrocytes are described as living in a niche of hypoxia, limited nutrients and high mechanical loads, which the review says requires precise metabolic regulation and mitochondrial quality control.
Supporting source [1]
Reviewed mechanisms: metabolism, inflammation and mitophagy
The review integrates recent mitochondrial biology to clarify how organelle dysfunction may promote endplate chondrocyte senescence. It analyzes a metabolic shift from oxidative phosphorylation to glycolysis and its impact on extracellular matrix stability. It then examines how mitochondrial reactive oxygen species activate the NLRP3 inflammasome and NF-κB pathways to drive the senescence-associated secretory phenotype. It also discusses fusion-fission imbalance and mitophagy failure leading to accumulation of damaged mitochondria, and how mito-nuclear communication may facilitate epigenetic remodeling that sustains senescent transcriptional programs.
Supporting source [1]
Evaluated interventions and proposed delivery approaches
The abstract says the review evaluates therapeutic interventions targeting mitochondrial homeostasis, including targeted antioxidants, NAD+ precursors and mitochondrial transplantation. To address delivery challenges in avascular cartilage, it also discusses the potential of cartilage-penetrating nanocarriers and gene-editing technologies. The review is presented as establishing a theoretical framework for developing etiology-based precision therapies for intervertebral disc degeneration; the abstract does not report tested treatments, outcomes or clinical results.
Supporting source [1]
How to interpret this
This is an abstract of a review; the full text was not reviewed. The abstract reports no study design, sample, follow-up or measured outcomes, and the proposed mechanisms and interventions are not presented as tested clinical results.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Tang R, Yin J, Li S, Wang S, Fei J, Zhou Z. · europepmc.org · August 13, 2026